Drugs / Policresulen
Policresulen
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02890277 | Jan 2016 → Dec 2017 | vulvar intraepithelial neoplasia | Jinan Military General Hospital | Unknown | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Policresulen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02890277 ↗ |
| Known as | Albocresil | ChEMBL registry synonym — accepted as the source's own label CHEMBL2106937 ↗ |
| Known as | Albothyl | “Albothyl (Policresulen Solution)” NCT02890277 ↗ |
| Known as | Negatol | ChEMBL registry synonym — accepted as the source's own label CHEMBL2106937 ↗ |
| Known as | Policresulene | ChEMBL registry synonym — accepted as the source's own label CHEMBL2106937 ↗ |
| Known as | Policresuleno | ChEMBL registry synonym — accepted as the source's own label CHEMBL2106937 ↗ |
| Modality | Small molecule | — CHEMBL2106937 ↗ |